Hepatitis

Alkan W. J. Evenchir Z. Eshchar J. (1965). Q fever and infectious hepatitis. American Journal of Medicine, 38, 54

Barker L. F. Shulman R. Murray R. Hirshman R. J. Ratner F. Diefenback W. C. L. Geller H. M. (1970). Transmission of serum hepatitis. Journal of the American Medical Association, 211, 1509

Bayer M. E. Blumberg B. S. Werner B. (1968). Particles associated with Australia antigen in the sera of patients with leukaemia, Down's syndrome and hepatitis. Nature (London), 218, 1057

Blumberg B. S. Alter H. J. Visnich S. (1965). A ‘new’ antigen in leukaemic sera. Journal of the American Medical Association, 191, 541

Blumberg B. S. Gerstley B. J. S. Hungerford D. A. Loudon W. T. Sutnick A. I. (1967). A serum antigen (Australia antigen) in Down's syndrome, leukaemia and hepatitis. Annals of Internal Medicine, 66, 924

Cook G. C. Velasco M. Sherlock S. (1968). Effect of corticosteroid therapy on bromsulphthalein excretion in active hepatitis. Gut, 9, 270

Cossart Y. Taylor P. E. Vahrman J. Zuckerman A. J. (1969). Australia-S.H. antigen in hepatitis patients in London. British Medical Journal, 3, 755

Dane D. S. Cameron C. H. Briggs M. (1970). Virus-like particles in serum of patients with Australian antigen-associated hepatitis. Lancet, 1, 695

Elton N. W. Romero A. Treyes A. (1955). Clinical pathology of the liver in yellow fever. American Journal of Clinical Pathology, 25, 135

Farrow L. J. Holborrow E. J. Johnson G. D. Lamb J. S. Taylor P. E. Zuckerman A. J. (1970) Auto-antibodies and the hepatitis-associated antigen in acute infective hepatitis. British Medical Journal, 2, 693

Flewett T. H. Parker R. G. F. Philip W. M. (1969) Acute hepatitis due to herpes-simplex virus in an adult. Journal of Clinical Pathology, 22, 60

Fox R. A. Niazi S. P. Sherlock S. (1969). Hepatitis-associated antigen in chronic liver disease. Lancet, 2, 609

Glade P. R. Kasel J. A. Moses H. L. Whang-Peng J. Hoffman P. F. Kammermayer J. K. Chessin L. N. (1968). Infectious mononucleosis; continuous suspension culture of peripheral blood leucocytes. Nature (London), 217, 654

Gocke D. J. Kavey N. B. (1969). Hepatitis antigen. Lancet, 1, 1055

Havens W. P. Jr. (1962). Viral hepatitis. Clinical patterns and diagnosis. American Journal of Medicine, 32, 665

Iber F. L. Mendeleff A. I. (1962). Prevention and treatment of viral hepatitis. Archives of Internal Medicine, 109, 310

Kilpatrick Z. M. (1966). Structural and functional abnormalities of liver in infectious mononucleosis. Archives of Internal Medicine, 117, 47

Koff R. S. Grady G. F. Chalmers T. C. Mosley J. W. Swartz B. L. (1967). Viral hepatitis from shellfish. New England Journal of Medicine, 276, 703

Krugman S. Giles J. P. Hammond J. (1965). Infectious hepatitis. Evidence for two distinctive clinical, epidemiological and immunological types of infection. Journal of the American Medical Association, 200, 365

Loudon W. T. Di Figlia M. Sutnick A. I. Blumberg B. S. (1969). An epidemic of hepatitis in a chronic-dialysis unit. Australia antigen and differences in host response. New England Journal of Medicine, 281, 571

Mackay I. R. Taft L. I. Cowling D. C. (1956). Lupoid hepatitis. Lancet, 2, 1323

Mackay I. R. Wieden S. Ungar B. (1964). Treatment of active chronic hepatitis and lupoid hepatitis with 6-mercaptopurine and azothioprine. Lancet, 1, 899

Maclachlan M. J. Rodman G. P. Cooper W. M. Fennell R. H. Jr. (1965). Chronic active (‘lupoid’) hepatitis. Annals of Internal Medicine, 62, 425

Mathews J. D. Mackay I. R. (1970). Australia antigen in chronic hepatitis in Australia. British Medical Journal, 1, 259

Melnick J. L. (1957). A water-borne urban epidemic of hepatitis. In Hepatitis Frontiers, p. 211. Boston: Little, Brown

Monif G. R. G. Asofsky R. Lever J. L. (1966). Hepatic dysfunction in the congenital rubella syndrome. Surgery, Gynecology and Obstetrics with International Abstracts of Surgery, 96, 215

Morris J. A. Elisberg B. L. Pond W. L. Webb P. A. (1962). Hepatitis associated with Coxsackie virus Group A, Type IV. New England Journal of Medicine, 267, 1230

Nefzger M. D. Chalmers T. C. (1963). The treatment of acute infectious hepatitis. Ten-year follow-up study of the effiects of diet and rest. American Journal of Medicine, 35, 299

Nowoslowski A. Brzosko W. J. Madelinski K. Krowczynski K. (1970). Cellular localisation of Australia antigen in liver of patients with lymphoproliferative disorders. Lancet, 1, 494

Prince A. M. (1968). Relation of Australia and S.H. antigens. Lancet, 2, 462

Rightsel W. A. Kelstch R. A. Taylor A. R. Biggs J. D. McLean I. W. Jr. (1961). Status report on tissue-culture cultivated hepatitis virus I. Virology laboratory studies. Journal of the American Medical Association, 177, 671

Rightsel W. A. (1967). Isolation of viruses from patients with hepatitis (1967). The Liver. Proceedings of 19th Symposium of the Colston Research Society, p. 201. Edited by Read A. E. A.

Saunders S. J. (1967). The treatment of hepatic coma by exchange blood transfusion. The Liver: Proceedings of 19th Symposium of the Colston Research Society, p. 289. Edited by Read A. E.

Shaldon S. Sherlock S. (1957). Virus hepatitis with features of prolonged bile retention. British Medical Journal, 2, 734

Sherlock S. (1966). Waldenstrom's chronic active hepatitis. Acta medica Scandinavia, 445, 427

Sherlock S. Fox R. A. Niazi S. P. Seltener P. J. (1970). Hepatitis-associated antigen, chronic hepatitis and cirrhosis. Gastroenterology.

Summerskill W. H. J. Clowdus B. F. Bollman J. L. Fleisher G. A. (1961). Clinical and experimental studies on the effect of Corticotropin and steroid drugs on bilirubinaemia. American Journal of Medical Sciences, 241, 555

Sun N. C. Smith V. M. (1966). Hepatitis associated with myocarditis. Unusual manifestation of infection with Coxsackie virus group B, type 3. New England Journal of Medicine, 274, 190

Toghill P. J. Bailey M. E. Williams R. Zeegan R. Bown R. (1967). Cytomegalovirus hepatitis in the adult. Lancet, 1, 1351

Trey C. and organising group (1968). Second progress report: Fulminant hepatic failure surveillance study. Boston: Thorndike Memorial Laboratory, Boston City Hospital.

Turner G. C. White G. B. B. (1969). S. H. antigen in haemodialysis-associated hepatitis. Lancet, 2, 121

Vischer T. L. (1970). Australia antigen and auto-antibodies in chronic hepatitis. British Medical Journal, 2, 695

Waldenstrom J. (1950). Leber, Blutptoreine and Nahrungseweiss Stoffwechs—Krh., Souderband: XV. Tagung, Bad Kissingen, p.8

Whittingham S. Mackay I. R. Irvine J. (1966(. Auto-immune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet, 1, 1333

Wigger H. J. Blanc W. A. (1966). Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia. New England Journal of Medicine, 275, 870

Williams R. Billing B. H. (1961). Action of steroid therapy in jaundice. Lancet, 2, 392

Wright R. McCollum R. W. Klatskin G. (1969). Australia antigen in acute and chronic liver disease. Lancet, 2, 118

Zuckerman A. J. Tsiquage K. N. Fulton F. (1967). Tissue culture of human embryo liver cells. Cytotoxicity of Anatoxin B1. British Journal of Experimental Pathology, 48, 20

Zuckerman A. J. Taylor P. E. Almeida J. D. (1970). Presence of particles other than Australia-S.H. antigen in a case of chronic active hepatitis with cirrhosis. British Medical Journal, 1, 262